CDEC recommends that Inspra not be listed for patients with NYHA class II systolic heart failure

[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \  \T \h \e \space \C \a \n \a \d \i \a \n \space \D \r \u \g \space \E \x \p \e \r \t \space \C \o \m \m \i \t \t \e \e \space \( \C \D \E \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \a \t \space \e \p \l \e \r \e \n \o \n \e \space \n \o \t \space \b \e \space \l \i \s \t \e \d \space \a \t \space \t \h \e \space \s \u \b \m \i \t \t \e \d \space \p \r \i \c \e " ..."]]
Read more →

CADTH’s 25th anniversary lecture series – Professor Christopher McCabe

As part of its 25th anniversary celebrations, CADTH has launched a special lecture series on health technology assessment (HTA) in Canada.
 
CADTH ...

Read more →

NICE recommends nalmefene to help people reduce their dependence on alcohol

In its draft guidance, NICE says nalmefene should be available as an option for those who regularly drink high amounts of ...

Read more →

Enzalutamide in prostate cancer: hints of added benefit

5 December 2013 - Enzalutamide (Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the ...
Read more →

NICE unable to give the go ahead to new prostate cancer drug in preliminary recommendations

[:content [\2 \4 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \N \I \C \E \, \space \t \h \e \space \h \e \a \l \t \h \c \a \r \e \space \g \u \i \d \a \n \c \e \space \b \o \d \y \, \space \h \a \s \space \i \s \s \u \e \d \space \n \e \w \  \d \r \a \f \t \  \g \u \i \d \a \n \c \e \space \n \o \t \space \r \e \c \o \m \m \e \n \d \i \n \g \  \r \a \d \i \u \m \space \R \a \space \2 \2 \3 \space \d \i \c \h \l \o \r \i \d \e \  \X \o \f \i \g \o \, \space \B \a \y \e \r \) \, \space \f \o \r \space \t \r \e \a \t \i \n \g \space \a \d \u \l \t \s " ..."]]
Read more →

NICE rejects Celgene's Revlimid again

Patients with a specific type of bone marrow disorder in England and Wales will be disappointed by news that cost ...

Read more →

NHS cancer chief: Further funding cuts 'likely'

The man in charge of a special NHS fund for cancer medicines in England has said there will need to ...

Read more →

Counting the cost of offering better care

Many will have seen the recent news that the first and only targeted chemotherapy drug for secondary breast cancer has ...

Read more →

Proposal to fund adalimumab and etanercept for the treatment of pyoderma gangrenosum

[:content [\4 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \P \H \A \R \M \A \C \space \i \s \space \s \e \e \k \i \n \g \space \f \e \e \d \b \a \c \k \space \o \n \space \a \space \p \r \o \p \o \s \a \l \space \t \o \space \a \m \e \n \d \space \t \h \e \space \l \i \s \t \i \n \g \space \o \f \space \t \w \o \space \t \u \m \o \u \r \space \n \e \c \r \o \s \i \s \space \f \a \c \t \o \r \space \i \n \h \i \b \i \t \o \r \s \, " ..."]]
Read more →

Recently added forthcoming submissions - April 2014 update

[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \B \e \l \o \w \space \i \s \space \a \space \l \i \s \t \space \o \f \space \f \o \r \t \h \c \o \m \i \n \g \space \s \u \b \m \i \s \s \i \o \n \s \space \t \h \a \t \space \h \a \v \e \space \r \e \c \e \n \t \l \y \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \t \h \e \space \S \M \C \' \s \space \w \o \r \k \  \p \r \o \g \r \a \m \m \e \. " ..."]]
Read more →

Government looks to Health Department for savings

An efficiency drive in the health department will save more than one billion dollars, the federal government says. ...

Read more →

NICE defends panels over conflict of interest claim

The National Institute for Health and Care Excellence has spoken out against renewed criticism of the way members of its ...

Read more →

New Zealand Pharmaceutical Schedule - July 2014 update

The July 2014 issue of the New Zealand Schedule of Pharmaceutical Benefits is now in effect. There are no listings ...

Read more →

Five new drugs for NHS Scotland

Cost regulators for National Health Service treatments in Scotland have approved five new medicines that will potentially benefit more than ...

Read more →

Presentations from ISPOR Australian Chapter Predicting Future Evidence Workshop

The presentations from the ISPOR Predicting Future Evidence Workshop in April 2015 are now available on the ISPOR-Australian Chapter website. ...

Read more →